<DOC>
	<DOCNO>NCT02293564</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety gevokizumab treatment active inflammatory , erosive osteoarthritis hand .</brief_summary>
	<brief_title>Open-label Safety Extension Study Gevokizumab Erosive Osteoarthritis Hand</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Diagnosis hand osteoarthritis Joint tenderness and/or redness At least one erosion Xray ( determined central reader ) Contraceptive measure adequate prevent pregnancy study History inflammatory disease hand erosive osteoarthritis ( EOA ) include : secondary posttraumatic osteoarthritis ( OA ) ; rheumatoid arthritis ; spondylarthropathies ; erosion ulnar styloid process ; psoriatic arthritis ; skin psoriasis ; erosion wrist ; fibromyalgia History gout , pseudogout , hemochromatosis History allergic anaphylactic reaction monoclonal antibody History recurrent chronic systemic infection Female subject pregnant , plan become pregnant , recently deliver , breastfeed Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Erosive Osteoarthritis</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Osteoarthritis Hand</keyword>
</DOC>